Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Julphar
Merck
Moodys
US Army
QuintilesIMS

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 7,902,202

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,902,202
Title:Compounds and pharmaceutical compositions for the treatment of viral infections
Abstract: Provided herein are compounds, compositions and methods for the treatment of liver disorder, including HCV and/or HBV infections. Specifically, compound and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
Inventor(s): Sommadossi; Jean-Pierre (Cambridge, MA), Gosselin; Gilles (Montpellier, FR), Pierra; Claire (Montarnaud, FR), Perigaud; Christian (Grabels, FR), Peyrottes; Suzanne (Grabels, FR)
Assignee: Idenix Pharmaceuticals, Inc. (Cambridge, MA) L\'Universite Montpellier II (Montpellier, FR)
Application Number:12/150,327
Patent Claims:see list of patent claims

Details for Patent 7,902,202

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Vidara Therapeutics Research Ltd ACTIMMUNE interferon gamma-1b VIAL; SINGLE-USE 103836 001 1999-02-25 ➤ Try a Free Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) L\'Universite Montpellier II (Montpellier, FR) ➤ Try a Free Trial RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07 ➤ Try a Free Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) L\'Universite Montpellier II (Montpellier, FR) ➤ Try a Free Trial RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07 ➤ Try a Free Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) L\'Universite Montpellier II (Montpellier, FR) ➤ Try a Free Trial RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Try a Free Trial Idenix Pharmaceuticals, Inc. (Cambridge, MA) L\'Universite Montpellier II (Montpellier, FR) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,902,202

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2008082601 Jul 10, 2008
World Intellectual Property Organization (WIPO) 2008082601 Oct 16, 2008
World Intellectual Property Organization (WIPO) 2008082602 Aug 28, 2008
World Intellectual Property Organization (WIPO) 2008082602 Jul 10, 2008
United States of America 2008261913 Oct 23, 2008
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Express Scripts
QuintilesIMS
Cipla
AstraZeneca
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.